For many tumors, abnormal FHIT gene regulatory transcription and FHIT protein deletion or re-education have been identified in a great variety of human tumors and tumor cell lines, such as lung cancer, breast cancer, cervical carcinoma, ovarian cancer, and so on [39-60]. This evidence concerns the gene FHIT and cervical carcinoma.